THY1 and hepatocellular carcinoma: In this study, we showed for the first time that rHGFK1 reduces the frequency of CD90+ CSCs in two HCC cell lines, ML-1 and HepG2, as indicated by the downregulation of the stemness-associated genes and the spherical formation ability of hyperspheres.